GlassScriptPhysician profile
Saiqa Choudhry
NPI 1043508450
$6,735.30
in general payments reported to CMS, 2019-2025
45 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.56 · 2021: $1,869 · 2022: $2,462 · 2023: $2,295 · 2024: $89.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323 · Education: $61.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.77 |
| Education | $61.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,051.39 | 2021-2023 | Tysabri, Vumerity, Avonex |
| Alexion Pharmaceuticals, INC. | $636.45 | 2021-2023 | Ultomiris, Soliris |
| Ucb, INC. | $398.78 | 2021-2023 | Briviact |
| Abbvie INC. | $371.40 | 2021-2023 | Qulipta, Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $294.29 | 2021-2023 | Austedo, Austedo Xr |
| Neurocrine Biosciences, INC. | $283.39 | 2021-2023 | Ingrezza, Ongentys |
| Celgene Corporation | $240.83 | 2021-2023 | Zeposia |
| Lilly USA, LLC | $231.93 | 2021-2023 | Reyvow, Emgality |
| Amgen INC. | $223.23 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $218.98 | 2022-2023 | Purified Cortrophin Gel |
| Amneal Pharmaceuticals LLC | $214.96 | 2021-2023 | Rytary |
| Genzyme Corporation | $189.17 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $174.58 | 2021-2023 | |
| Tanabe Pharma America, INC. | $165.65 | 2021-2023 | |
| Neurelis, INC. | $156.76 | 2021-2023 | Valtoco |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saiqa Choudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.